Elaine Soffer

482 total citations
18 papers, 371 citations indexed

About

Elaine Soffer is a scholar working on Surgery, Gastroenterology and Molecular Biology. According to data from OpenAlex, Elaine Soffer has authored 18 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Gastroenterology and 7 papers in Molecular Biology. Recurrent topics in Elaine Soffer's work include Helicobacter pylori-related gastroenterology studies (9 papers), Gastroesophageal reflux and treatments (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Elaine Soffer is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (9 papers), Gastroesophageal reflux and treatments (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Elaine Soffer collaborates with scholars based in United States and Canada. Elaine Soffer's co-authors include Gail M. Comer, David C. Metz, Wieslaw Bochenek, Samuel Pace, Dennis M. Jensen, Julie Starr, Christopher E. Forsmark, Edward A. Lew, Joseph R. Pisegna and John H. Walsh and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Archives of Biochemistry and Biophysics.

In The Last Decade

Elaine Soffer

18 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elaine Soffer United States 10 222 220 98 62 51 18 371
V. Londong Germany 8 187 0.8× 146 0.7× 61 0.6× 5 0.1× 60 1.2× 11 321
B. Lembcke Germany 8 134 0.6× 21 0.1× 113 1.2× 17 0.3× 64 1.3× 23 278
Mohannad Dugum United States 9 77 0.3× 49 0.2× 112 1.1× 6 0.1× 15 0.3× 24 288
Angelo Italia Italy 8 128 0.6× 26 0.1× 122 1.2× 5 0.1× 24 0.5× 23 323
Suntje Sander‐Struckmeier United States 11 306 1.4× 22 0.1× 63 0.6× 5 0.1× 52 1.0× 17 460
Rafael Amaro United States 9 165 0.7× 107 0.5× 39 0.4× 4 0.1× 41 0.8× 20 299
K. Samuelson Sweden 10 149 0.7× 70 0.3× 46 0.5× 2 0.0× 65 1.3× 21 343
Hiromi Imazeki Japan 6 78 0.4× 16 0.1× 85 0.9× 11 0.2× 17 0.3× 7 260
R Nilius Germany 7 117 0.5× 11 0.1× 221 2.3× 18 0.3× 14 0.3× 29 341
Nipaporn Pichetshote United States 8 111 0.5× 53 0.2× 35 0.4× 3 0.0× 18 0.4× 23 268

Countries citing papers authored by Elaine Soffer

Since Specialization
Citations

This map shows the geographic impact of Elaine Soffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Soffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Soffer more than expected).

Fields of papers citing papers by Elaine Soffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Soffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Soffer. The network helps show where Elaine Soffer may publish in the future.

Co-authorship network of co-authors of Elaine Soffer

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Soffer. A scholar is included among the top collaborators of Elaine Soffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Soffer. Elaine Soffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hogan, Daniel L., Dennis Riff, Hillel T. Schwartz, et al.. (2007). Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro‐oesophageal reflux disease and a history of erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 26(2). 249–256. 6 indexed citations
2.
Metz, David C., Gail M. Comer, Elaine Soffer, et al.. (2006). Three‐year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions. Alimentary Pharmacology & Therapeutics. 23(3). 437–444. 31 indexed citations
3.
Jensen, Dennis M., Samuel Pace, Elaine Soffer, & Gail M. Comer. (2006). Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study. The American Journal of Gastroenterology. 101(9). 1991–1999. 51 indexed citations
5.
Tolia, Vasundhara, et al.. (2006). Multicenter, Randomized, Double‐Blind Study Comparing 10, 20 and 40 mg Pantoprazole in Children (5‐11 Years) With Symptomatic Gastroesophageal Reflux Disease. Journal of Pediatric Gastroenterology and Nutrition. 42(4). 384–391. 49 indexed citations
6.
Jensen, Dennis M., Samuel Pace, Elaine Soffer, M. Mack, & Gail M. Comer. (2004). LOWER REBLEEDING RATES IN HIGH RISK PATIENTS TREATED WITH IV PANTOPRAZOLE THAN IV RANITIDINE AFTER ENDOSCOPIC HEMOSTASIS IN A RANDOMIZED CONTROLLED US STUDY. The American Journal of Gastroenterology. 99. S296–S296. 6 indexed citations
7.
Metz, David C., Elaine Soffer, Chris E. Forsmark, et al.. (2003). Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. The American Journal of Gastroenterology. 98(2). 301–307. 25 indexed citations
8.
Pratha, Vijaya S., George J. Wan, Elaine Soffer, Daniel J. Hogan, & Wenjin Wang. (2003). PANTOPRAZOLE POSITIVELY IMPACTS NIGHTTIME HEARTBURN SYMPTOMS AND QUALITY OF SLEEP IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. The American Journal of Gastroenterology. 98. S234–S235. 1 indexed citations
9.
Jensen, Dennis M., et al.. (2003). Lower rebleeding rates than expected in an ongoing study comparing intravenous pantoprazole to ranitidine to prevent peptic ulcer rebleeding. Gastroenterology. 124(4). A627–A627. 1 indexed citations
10.
Metz, David C., Géraldine M. Ferron, Jeffrey Paul, et al.. (2002). Proton Pump Activation in Stimulated Parietal Cells Is Regulated by Gastric Acid Secretory Capacity: A Human Study. The Journal of Clinical Pharmacology. 42(5). 512–519. 18 indexed citations
11.
Metz, David C., Christopher E. Forsmark, Edward A. Lew, et al.. (2001). Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. The American Journal of Gastroenterology. 96(12). 3274–3280. 35 indexed citations
12.
Lew, Edward A., Joseph R. Pisegna, Julie Starr, et al.. (2000). Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger–Ellison syndrome. Gastroenterology. 118(4). 696–704. 81 indexed citations
13.
14.
Dressler, Dawna, et al.. (1985). Determination of promethazine in human plasma by automated high-performance liquid chromatography with electrochemical detection and by gas chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 339(1). 105–115. 24 indexed citations
15.
Soffer, Elaine, et al.. (1982). Mechanism of polymeric prostaglandin PGBx for in vitro stabilization of rat liver mitochondrial oxidative phosphorylation.. PubMed. 14(5). 445–69. 2 indexed citations
16.
Soffer, Elaine, et al.. (1982). Studies on the mechanism of mitochondrial protection by polymeric prostaglandin PGBx.. PubMed. 14(5). 471–86. 4 indexed citations
17.
Soffer, Elaine, et al.. (1981). Interaction of bovine serum albumin with PGBx (polymeric 15-keto-prostaglandin B1).. PubMed. 13(3). 241–50. 1 indexed citations
18.
Schwarz, H. P., et al.. (1965). Effect of whole-body X-ray irradiation on phospholipids of rat liver particulate fractions. Archives of Biochemistry and Biophysics. 111(2). 422–430. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026